Ibucomp (Pseudoephedrine Hydrochloride, Ibuprofen)

Ibuprofen blocks cyclooxygenase enzymes, lowering prostaglandin production and thereby reducing pain, fever, and inflammation. Pseudoephedrine stimulates α‑adrenergic receptors, causing blood‑vessel constriction in the nasal mucosa, which decreases swelling and eases breathing.

The appropriate dose is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical condition. Patients should follow the prescriber’s instructions and the product label without exceeding the recommended amount.

Safety data for the combined use of ibuprofen and pseudoephedrine during pregnancy or lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should consult their physician before using Ibucomp.

To place an order, submit an enquiry on the Ibucomp product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibucomp offers the convenience of a single tablet that delivers both analgesic/antipyretic action (ibuprofen) and nasal decongestion (pseudoephedrine). Separate products require taking two different medicines, which may increase pill burden and the risk of dosing errors. However, the combined formulation may not be suitable for patients who need only one of the components.

Store Ibucomp at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Ibucomp is taken orally with a full glass of water. It may be taken with or without food, but taking it with food can reduce stomach irritation. Swallow the tablet whole; do not crush or chew it.

Serious risks include severe allergic reactions such as anaphylaxis, gastrointestinal bleeding, and a significant rise in blood pressure. If any of these occur—characterized by rash, vomiting blood, black stools, or sudden hypertension—seek immediate medical attention.

Ibucomp should be avoided by individuals with known hypersensitivity to ibuprofen, pseudoephedrine, or any excipients, as well as those with uncontrolled hypertension, active peptic ulcer disease, severe renal or hepatic impairment, or who are currently taking monoamine oxidase inhibitors.